| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Matrix metalloproteinasePD166793TIMPNeoplasia (Tumor biology and immunology)Atherosclerosis (peripheral vessels)Neoplasia (Invasion and metastasis)Cell migrationInvadopodiaMT1 MMP MMP14EstrogenLymphangioleiomyomatosisMMP2Diabetes mellitus (Involvement kidney)Extracellular matrixFibrinolysis| 1 | 2008 | Inhibiting metalloproteases with PD 166793 in heart failure: impact on cardiac remodeling and beyond. | 
| + | - | nl | Cardiovasc Ther 26(1):24-37 (2008) |
| 2 | 2006 | Structure and function of matrix metalloproteinases and TIMPs. | 
| + | - | nl | Cardiovasc Res 69(3):562-73 (2006) |
| 3 | 1998 | Treatment of central nervous system inflammation with inhibitors of basement membrane degradation. | 
| + | - | nl | Immunol Cell Biol 76(1):104-13 (1998) |
| 4 | 2008 | Gelatinases mediate neutrophil recruitment in vivo: evidence for stimulus specificity and a critical role in collagen IV remodeling. | 
| + | - | nl | J Leukoc Biol 83(4):864-74 (2008) |
| 5 | 1993 | Matrix metalloproteinases: a review. | 
| + | - | nl | Crit Rev Oral Biol Med 4(2):197-250 (1993) |
| 6 | 2007 | Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. | 
| + | - | nl | Physiol Rev 87(4):1285-342 (2007) |
| 7 | 2007 | Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. | 
| + | - | nl | Physiol Rev 87(1):69-98 (2007) |
| 8 | 2005 | Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. | 
| + | - | nl | Physiol Rev 85(1):1-31 (2005) |
| 9 | 1998 | Matrix metalloproteinases: structures, evolution, and diversification. | 
| + | - | nl | FASEB J 12(12):1075-95 (1998) |
| 10 | 1993 | Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. | 
| + | - | nl | FASEB J 7(15):1434-41 (1993) |
| 11 | 1991 | Matrix metalloproteinases and their inhibitors in connective tissue remodeling. | 
| + | - | nl | FASEB J 5(8):2145-54 (1991) |
| 12 | 2007 | Role of matrix metalloproteinases in renal pathophysiologies. | 
| + | - | nl | Am J Physiol Renal Physiol 292(3):F905-11 (2007) |
| 13 | 2003 | Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. | 
| + | - | nl | Circ Res 92(8):827-39 (2003) |
| 14 | 2001 | Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? | 
| + | - | nl | Circ Res 89(3):201-10 (2001) |
| 15 | 1994 | The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. | 
| + | - | nl | Eur Respir J 7(11):2062-72 (1994) |
| 16 | 2006 | Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. | 
| + | - | nl | Exp Biol Med (Maywood) 231(1):20-7 (2006) |
| 17 | 2000 | Matrix metalloproteinases: effectors of development and normal physiology. | 
| + | - | nl | Genes Dev 14(17):2123-33 (2000) |
| 18 | 2003 | Matrix metalloproteinases: old dogs with new tricks. | 
| + | - | nl | Genome Biol 4(6):216 (2003) |
| 19 | 1999 | Matrix metalloproteinases. | 
| + | - | nl | J Biol Chem 274(31):21491-4 (1999) |
| 20 | 2011 | Physiology and pathophysiology of matrix metalloproteases. | 
| + | - | nl | Amino Acids 41(2):271-90 (2011) |
| 21 | 2010 | Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. | 
| + | - | nl | Biochim Biophys Acta 1803(1):133-41 (2010) |
| 22 | 2010 | Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. | 
| + | - | nl | Biochim Biophys Acta 1803(1):103-20 (2010) |
| 23 | 2008 | Bone-marrow-derived matrix metalloproteinase-14: a novel target for plaque stability. | 
| + | - | nl | Circulation 117(7):863-5 (2008) Shimokawa H |
| 24 | 2002 | Matrix metalloproteinases: regulation and dysregulation in the failing heart. | 
| + | - | nl | Circ Res 90(5):520-30 (2002) |
| 25 | 2009 | Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. | 
| + | - | nl | J Cell Sci 122(Pt 17):3015-24 (2009) |
| 26 | 2008 | Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase-induced cell invasiveness. | 
| + | - | nl | J Clin Endocrinol Metab 93(5):1625-33 (2008) |
| 27 | 2009 | Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy. | 
| + | - | nl | Endocrine 35(1):1-10 (2009) |
| 28 | 2004 | Regulation of matrix biology by matrix metalloproteinases. | 
| + | - | nl | Curr Opin Cell Biol 16(5):558-64 (2004) |
| 29 | 2002 | Matrix metalloproteinases and cellular fibrinolytic activity. | 
| + | - | nl | Biochemistry (Mosc) 67(1):92-8 (2002) |
| 30 | 2009 | Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. | 
| + | - | nl | Clin Microbiol Rev 22(2):224-39, Table of Contents (2009) |
| 31 | 2003 | Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. | 
| + | - | nl | Br J Cancer 89(10):1817-21 (2003) |
| 32 | 2006 | Metzincins, including matrix metalloproteinases and meprin, in kidney transplantation. | 
| + | - | nl | Swiss Med Wkly 136(49-50):789-94 (2006) |